Emerging Biotech
IASO Biotechnology , a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody pr...
July 01, 2024 | News
Developed a 'Niclosamide-based multi-treatment drug' that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus...
June 26, 2024 | News
Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singl...
June 19, 2024 | News
Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...
June 17, 2024 | News
The Thailand Board of Investment (BOI) today approved investment promotion applications for eight large-scale projects totaling 56.95 billion baht (USD 1.5...
June 17, 2024 | News
Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...
June 14, 2024 | News
Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is ...
June 14, 2024 | News
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...
June 13, 2024 | News
Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...
June 11, 2024 | News
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...
June 07, 2024 | News
Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...
May 27, 2024 | News
Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...
May 24, 2024 | News
RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...
May 22, 2024 | News
➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against ...
May 15, 2024 | News
Most Read
Bio Jobs
News